Featured image: Cigarette butts in an ashtray in Los Angeles, California, May 31, 2012. Photo: Reuters/Jonathan Alcorn
Los Angeles: Using lab-grown lung tissue, scientists have pinpointed how smoking cigarettes facilitates more severe lung infection by the novel coronavirus, an advance that may lead to new therapeutic strategies to help reduce smokers’ chances of developing severe COVID-19.
According to the researchers, including those from the University of California Los Angeles (UCLA) in the US, the findings also shed more light on the COVID-19 risks for smokers.
While several studies of COVID-19 patients have indicated that current smokers are at increased risk of severe infection and death due to the coronavirus infection, they said the reasons have not been entirely clear.
In the current research, published in the journal Cell Stem Cell, the scientists recreated what happens when the airways of a current smoker are infected with the novel coronavirus SARS-CoV-2.
The researchers utilised a platform known as an air-liquid interface culture, which is grown from unspecialised cells called human airway stem cells, and closely replicated how these behave and function in humans.
The airways, which carry air breathed in from the nose and mouth to the lungs, are the body’s first line of defence against airborne pathogens like viruses, bacteria and smoke, the scientists said.
“Our model replicates the upper part of the airways, which is the first place the virus hits,” said Brigitte Gomperts, a co-author of the study from UCLA.
“This is the part that produces mucus to trap viruses, bacteria and toxins and contains cells with finger-like projections that beat that mucus up and out of the body,” Gomperts added.
Since these stem cells were taken from the lungs of healthy, nonsmoking tissue donors, the researchers replicated the effects of smoking by exposing the airway cultures to cigarette smoke for three minutes per day over four days.
“This type of model has been used to study lung diseases for over a decade and has been shown to mimic the changes in the airway that you would see in a person who currently smokes,” Gomperts explained.
The researchers then infected the cultures exposed to cigarette smoke – along with identical cultures that had not been exposed – with live SARS-CoV-2 virus and compared the two groups.
In the models exposed to smoke, the scientists reported between two and three times more infected cells.
According to the researchers, smoking may have resulted in more severe SARS-CoV-2 infection, at least in part, by blocking the activity of immune system messenger proteins called interferons.
They said interferons play a critical role in the body’s early immune response by triggering infected cells to produce proteins to attack the virus, summoning additional support from the immune system, and alerting uninfected cells to prepare to fight the virus.
“If you think of the airways like the high walls that protect a castle, smoking cigarettes is like creating holes in these walls. Smoking reduces the natural defences and that allows the virus to set in,” Gomperts said.